How long can you stay on nattokinase?

There is no fixed expiry date on nattokinase, but there is a gap between what the label on a Canadian bottle tells you and what the research actually supports.

Most nattokinase products sold in Canada carry a statement advising you to consult a health care practitioner for use beyond four weeks. Yet the longest clinical trial ever run kept participants on 2,000 fibrinolytic units daily for a median of three years [1]. Both facts are true. Understanding why they differ is the key to deciding how long you should stay on it.

Table of Contents

• The Short Answer
• Where the 4-Week Label Limit Comes From
• The Longest Study: Three Years at 2,000 FU
• What Long-Term Use Does and Doesn't Deliver
• Who Should Not Stay on Nattokinase Long-Term
• What Happens When You Stop
• Stopping for Surgery, Dental Work and Procedures
• A Practical Long-Term Protocol
• How BioAbsorb Approaches This
• Frequently Asked Questions
• Conclusion
• Research References

The Short Answer

How long can you stay on nattokinase? For most healthy adults without bleeding risk factors, the available evidence supports continuous daily use well beyond a few months — but the responsible answer is that you should not stay on it indefinitely without periodic medical review.

That is not a hedge. It reflects two separate things: a regulatory position and an evidence base, which do not line up neatly.

The regulatory position, in Canada, is a four-week checkpoint. The evidence base extends to three years of randomized, placebo-controlled exposure. Neither tells you that nattokinase becomes dangerous on a particular day. What they jointly suggest is that long-term use is reasonable for the right person, and that "the right person" is a determination made with a practitioner rather than assumed.

Where the 4-Week Label Limit Comes From

If you buy nattokinase in Canada, the label almost certainly says to consult a health care practitioner for use beyond four weeks. This appears on 2,000 FU products from multiple Canadian brands and is not a manufacturer's choice — it comes from the conditions of use that Health Canada sets through its Compendium of Monographs [9], which licence holders reference when applying to sell a natural health product.

It is easy to misread this as a safety ceiling. It is better understood as a review trigger. Regulators apply duration statements when an ingredient's long-term dataset is thinner than its short-term one, and when the ingredient interacts with something that warrants monitoring. Both apply here.

Health Canada has been notably cautious about nattokinase. Its 2012 assessment concluded that safety concerns, including the potential for increased bleeding risk, had not been adequately addressed [8]. That caution is reflected in the accompanying label cautions, which are more informative than the four-week line itself: do not use if pregnant or breastfeeding, if you have a bleeding disorder, or if you take products affecting blood coagulation; stop seven days before scheduled surgery, or immediately after any injury causing bruising or bleeding; and consult a practitioner if you have a cardiovascular, kidney, or liver disorder.

Read together, the message is that the risk profile is about who you are and what else you take, not about how many months have elapsed.

The Longest Study: Three Years at 2,000 FU

The single most useful piece of evidence on this question is the Nattokinase Atherothrombotic Prevention Study, published in Clinical Hemorheology and Microcirculation in 2021.

It was a double-blind randomized trial in which 265 individuals of median age 65.3, with no clinical evidence of cardiovascular disease, received either 2,000 fibrinolytic units of nattokinase daily or matching placebo [1]. Participants were monitored with serial carotid ultrasound every six months, alongside blood pressure, metabolic factors, blood rheology, coagulation and fibrinolysis markers, and inflammatory markers. Treatment continued for a median of three years.

No other nattokinase trial comes close to this duration. For someone asking how long they can safely stay on the enzyme, it is the closest thing to a direct answer that exists: three years of continuous supervised daily use at exactly the dose in most consumer products, with laboratory monitoring throughout, and no safety signal reported.

Supporting evidence points the same way. A 2023 systematic review and meta-analysis pooling six randomized controlled trials and 546 participants reported no notable adverse events in any included trial [3]. A drug information monograph summarising the literature notes that trials enrolling small numbers of patients for up to seven months reported no adverse reactions, and that a four-week trial found no substantial effect on hematologic, renal, or hepatic laboratory tests [8]. A 2025 review in Nutrients similarly describes a favourable safety profile in people taking nattokinase long term [5], with occasional mild gastrointestinal effects that tend to settle with adjustment.

What Long-Term Use Does and Doesn't Deliver

Here is where honesty matters more than reassurance, because staying on any supplement indefinitely only makes sense if it is doing something.

The three-year trial described above did not just report safety. It also reported results — and they were null. The annualized rate of change in carotid intima-media thickness and carotid arterial stiffness did not differ significantly between the nattokinase and placebo groups, and there was no significant effect on blood pressure or on any laboratory determination [1]. The authors concluded that supplementation had a null effect on subclinical atherosclerosis progression in healthy individuals at low cardiovascular risk.

That finding sits alongside more encouraging shorter-term data. The foundational trial published in Hypertension Research in 2008 randomized 86 adults with untreated systolic pressure of 130 to 159 mmHg to 2,000 FU or placebo for eight weeks, finding net reductions of 5.55 mmHg systolic and 2.84 mmHg diastolic [2]. The 2023 meta-analysis found a pooled systolic reduction of 3.45 mmHg [3]. A multicentre North American trial reported a significant reduction in diastolic blood pressure, with a smaller, non-significant downward trend in von Willebrand factor [6], a cardiovascular risk marker.

Dose appears to matter considerably. A retrospective study of 1,062 participants who took nattokinase for 12 months found significant reductions in carotid intima-media thickness and plaque size at 10,800 FU daily, with improvement rates from 66.5% to 95.4% — but reported the enzyme ineffective at 3,600 FU daily [4]. That study had no placebo group and reviewed records of people already taking the supplement, so it carries far less weight than a randomized trial. Its own authors acknowledged the contrast with the null 2,000 FU finding [4] and called for further work.

The practical reading: the strongest case for staying on nattokinase long term is modest blood pressure support in people with pre-hypertension or stage 1 hypertension. The case for taking it for years to reverse arterial plaque at standard doses is not supported by the best available trial. If you want the fuller picture on that question, our article on whether nattokinase dissolves arterial plaque goes into the evidence in detail, and our review of the blood pressure research covers the trials above.

Who Should Not Stay on Nattokinase Long-Term

Duration risk is concentrated in specific groups rather than spread evenly across everyone.

The clearest contraindications, drawn directly from Canadian product labelling, are pregnancy and breastfeeding, existing bleeding disorders, and concurrent use of any product affecting blood coagulation. Anyone with a cardiovascular, kidney, or liver disorder is advised to involve a practitioner. Anyone with a history of hypersensitivity reactions to natto should avoid nattokinase entirely — natto can rarely cause late-onset anaphylaxis with symptom onset 4 to 15 hours after ingestion, with poly-gamma-glutamic acid from the fermentation process implicated by skin testing [8].

The most serious documented harm involves substitution rather than duration. A case report describes a patient with a mechanical aortic valve who replaced warfarin with nattokinase at 100 mg per day and developed valve thrombosis requiring replacement roughly a year later [8]. Nattokinase is not a substitute for prescribed anticoagulation, and no length of use changes that.

Combination effects also compound over time simply because exposure does. If you are layering nattokinase with other agents that affect clotting, the relevant question is not months elapsed but total antithrombotic load — our piece on combining turmeric and nattokinase works through one common example, and the discussion of stroke and bleeding risk covers the hemorrhagic side.

Finally, surgery is a hard interruption at any duration. Labels advise stopping seven days before a scheduled procedure, or immediately in the case of unscheduled surgery or an injury causing bruising or bleeding.

What Happens When You Stop

Nattokinase does not appear to create dependence, and there is no established withdrawal or rebound syndrome. It is an enzyme taken orally, not a hormone or a receptor-acting drug, and its measurable effects on fibrinolytic markers are transient.

Researchers have explicitly studied cessation. A registered trial gave participants nattokinase for eight weeks and then had them stop for two weeks, specifically to evaluate the effect of both long-term intake and its cessation [7] on fibrinolytic factors, vital signs, blood lipids, and renal function. The design reflects the sensible assumption that benefits, where present, depend on continued intake.

That is the more useful framing. If nattokinase is helping your blood pressure, stopping means losing that support, in the same way stopping any blood pressure intervention would. It does not mean a dangerous rebound. This also means a trial interruption is a low-risk way to assess whether the supplement is doing anything for you — something worth discussing at the four-week review point. Our guide on how to tell if nattokinase is working covers which markers are actually measurable.

Stopping for Surgery, Dental Work and Procedures

Most people who need to stop nattokinase are not stopping permanently — they are pausing for a procedure. The standard guidance is to stop around two weeks beforehand, which gives fibrinolytic activity time to return to baseline before anything is cut.

The case people get wrong is the "minor" one. A dental extraction, a deep cleaning that draws blood, a colonoscopy with a polyp removed, a skin biopsy — none of these feels like surgery, and all of them involve bleeding that a fibrinolytic enzyme can prolong. The two-week rule applies to all of them.

Tell whoever is performing the procedure that you take it, even if you have already stopped. Supplements are routinely left off medication lists because patients do not think of them as medication, and a surgeon who knows can plan around it. One who does not, cannot.

Restarting is the easier half: resume when the person who performed the procedure says the wound is healed and clotting normally. There is no tapering requirement — nattokinase has no withdrawal effect, so resumption is simply resumption.

A Practical Long-Term Protocol

A defensible approach for a healthy adult with no bleeding risk factors, built around the regulatory checkpoint rather than against it:

1. Weeks 1–4. Establish a baseline before you start — blood pressure readings, and any lipid or coagulation labs your practitioner considers relevant. Take a consistent daily dose at a consistent time.
2. At 4 weeks. This is the label's review point. Bring your baseline and current readings to a practitioner. Confirm nothing in your medication list has changed, and agree whether continuing is appropriate.
3. Months 2–6. If continuing, monitor blood pressure periodically rather than daily, and stay alert to easy bruising, unusual bleeding, or prolonged bleeding from minor cuts.
4. Every 6 months thereafter. This mirrors the monitoring interval used in the three-year trial. Reassess whether the supplement is still earning its place, and repeat relevant labs.
5. Always. Pause seven days before scheduled surgery or dental procedures. Reassess immediately if you start any anticoagulant, antiplatelet, or new supplement affecting clotting.

Dose consistency matters as much as duration. Our nattokinase dosage guide covers the FU ranges used in trials and the reasoning behind timing.

How BioAbsorb Approaches This

BioAbsorb Nutraceuticals formulates its Nattokinase Enzyme around the dose that carries the deepest research record rather than the highest number on the shelf. Each capsule delivers 100 mg of nattokinase standardised to 2,000 fibrinolytic units — the same activity level used in the eight-week blood pressure trial and in the three-year atherothrombotic prevention study. When you are considering months or years of daily use, being aligned with the dose that has actually been studied over long periods is the relevant safety consideration.

The capsule uses DRcaps delayed-release technology, which protects the enzyme from stomach acid so it arrives intact in the small intestine, without the phthalates and plasticizers found in conventional enteric coatings. For someone taking a capsule every day for a year or more, cumulative exposure to capsule materials is a fair thing to care about.

Every batch is third-party tested for nattokinase activity at or above 2,000 FU per capsule, and for heavy metals, gluten, and microbial contaminants. Potency verification matters especially for long-term users, since an enzyme that has degraded in storage delivers less than the label claims. The formulation is non-GMO, manufactured in a GMP-certified facility in Canada, and free from gluten, nuts, eggs, dairy, fish, shellfish, and all animal products.

We would rather you take this supplement with your practitioner's knowledge than take more of it on your own. The four-week review on Canadian labelling is a reasonable practice, and we encourage customers to treat it as one.

Frequently Asked Questions

Can I take nattokinase every day indefinitely?

There is randomized trial evidence supporting daily use at 2,000 FU for a median of three years without a reported safety signal. Canadian labelling still advises consulting a practitioner beyond four weeks, so indefinite use should be a supervised decision rather than a default one.

Does nattokinase lose effectiveness over time?

There is no established tolerance mechanism for nattokinase, and no trial has demonstrated diminishing response with continued use. That said, the longest trial found no measurable cardiovascular effect at 2,000 FU over three years, so the more useful question is whether it was producing a measurable benefit for you in the first place.

Do I need to take breaks or cycle off?

No published evidence supports mandatory cycling, and no rebound effect has been documented on stopping. A planned interruption can still be useful as a personal test of whether the supplement is contributing anything measurable, particularly around your practitioner review.

Is long-term nattokinase safe with blood thinners?

Canadian labelling advises against use with any product affecting blood coagulation, and this applies regardless of duration. Nattokinase should never be used as a replacement for prescribed anticoagulation — a documented case describes valve thrombosis after such a substitution.

What should I monitor if I stay on it for years?

Blood pressure is the most relevant routine measure, given it is the outcome with the strongest supporting evidence. Watch for easy bruising or prolonged bleeding, and ask your practitioner whether periodic coagulation, kidney, or liver labs are appropriate for your situation.

Do I need to stop before surgery?

Yes. Product labelling advises stopping seven days before any scheduled surgery, and immediately in the case of unscheduled surgery or an injury causing bruising or bleeding. Tell your surgical and dental teams that you take it.

Do I need to stop before a dental cleaning?

For a routine polish, generally not. For anything that draws blood — a deep scaling, an extraction, any oral surgery — apply the same two-week rule as for surgery, and tell your dentist either way. Dental procedures are where this is most often overlooked.

My doctor has just prescribed a blood thinner. Should I stop nattokinase?

Stop, and raise it at your next contact rather than continuing quietly. A prescribed anticoagulant plus a fibrinolytic supplement is additive, and your prescriber has dosed the medication on the assumption that it is working alone. This is information they need.

Conclusion

The honest answer to how long you can stay on nattokinase is that safety data supports years rather than weeks, while Canadian labelling asks you to check in with a practitioner at four weeks — and both deserve respect. Decide based on whether it is measurably helping you, not on how long the bottle has been on your counter. If you are continuing long term, a consistently dosed and independently tested product is the sensible foundation: see the BioAbsorb Nattokinase Enzyme.

Research References

1. Hodis HN, Mack WJ, Meiselman HJ, et al. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clinical Hemorheology and Microcirculation, Vol. 78, Issue 4, 2021, pp. 339–353. PubMed
2. Kim JY, Gum SN, Paik JK, et al. Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertension Research, Vol. 31, Issue 8, 2008, pp. 1583–1588. Nature
3. Li X, Long J, Gao Q, et al. Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials. Reviews in Cardiovascular Medicine, Vol. 24, Issue 8, Article 234, 2023. IMR Press · PubMed
4. Chen H, Chen J, Zhang F, et al. Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: a clinical study with 1,062 participants. Frontiers in Cardiovascular Medicine, Vol. 9, Article 964977, 2022. Frontiers · PMC
5. Wei C, Cai R, Song Y, et al. Research progress of nattokinase in reducing blood lipid. Nutrients, Vol. 17, Issue 11, Article 1784, 2025. MDPI
6. Jensen GS, Lenninger M, Ero MP, Benson KF. Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integrated Blood Pressure Control, Vol. 9, 2016, pp. 95–104. Taylor & Francis
7. Efficacy and Safety of Natto Extract (NCT00447434). ClinicalTrials.gov. ClinicalTrials.gov
8. Nattokinase: uses, benefits and dosage. Professional natural products monograph, Drugs.com. Drugs.com
9. Compendium of Monographs. Natural and Non-prescription Health Products Directorate, Health Canada. Government of Canada
10. Nattokinase NSK-SD 2,000 FU product labelling, Flora Health Canada. Flora Health
11. Nattokinase product labelling, Natural Factors Canada. Natural Factors

---

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.